Abstract

Autoimmune hepatitis is a chronic Progressive liver disease. Patients vvith autoimmune hepatitis usually respond to immu-nosuppressive treatment. Treatment vvith corticosteroids and azathioprine is a milestone in achieving remission but other immu-nosuppressive drugs are also used when necessary. Development of malignancies follovving immunosuppressive treatment is well-known. İn addition, lymphoproliferative disorders associated vvith autoimmune diseases has been reported previously. Co-existence of autoimmune hepatitis and malignancies in other tissues, hovvever, has not been presented before. İn this report, we presented a case vvith autoimmune hepatitis developing thyroid papillary carcinoma 17 months after the initiation of therapy.